Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.320 | None | 1.000 | 7 | 0 | 1997 | 2011 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.150 | None | 1.000 | 7 | 3 | 1991 | 2016 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2016 | 2018 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.370 | None | 1.000 | 7 | 0 | 1988 | 1998 | ||||||||
|
notch receptor 1 | 0.369 | 0.885 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2019 | ||||||||
|
Fas cell surface death receptor | 0.372 | 0.923 | 0.81 |
|
disease | 0.100 | None | 1.000 | 3 | 3 | 2013 | 2017 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
disease | 0.310 | None | 0.500 | 2 | 0 | 1999 | 2014 | ||||||||
|
microRNA 155 | 0.384 | 0.885 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
interleukin 13 | 0.386 | 0.846 | 1.4E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
keratin 20 | 0.388 | 0.846 | 9.1E-11 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1992 | 1994 | ||||||||
|
caspase 8 | 0.404 | 0.923 | 3.7E-06 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
membrane metalloendopeptidase | 0.407 | 0.808 | 1.5E-18 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1994 | 1994 | ||||||||
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
lysine methyltransferase 2A | 0.410 | 0.885 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1987 | 1987 | ||||||||
|
membrane spanning 4-domains A1 | 0.411 | 0.846 | 5.1E-05 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1992 | 1994 | ||||||||
|
CD40 ligand | 0.414 | 0.846 | 0.72 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1975 | 1995 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
ETS proto-oncogene 1, transcription factor | 0.444 | 0.731 | 0.78 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1988 | 1988 | ||||||||
|
RAD51 recombinase | 0.447 | 0.846 | 2.7E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
purinergic receptor P2X 7 | 0.450 | 0.808 | 3.3E-11 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2002 | 2002 |